Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m

Updated on: March 12,2024 10

Researchers identify novel oncogenic function for receptor linked to Alzheimer's disease

by University of TurkuCredit: CC0 Public DomainCommon and rare SORLA single nucleotide polymorphisms have been associated with the development of Alzheimer's disease. So far, SORLA has been m

Updated on:March 12,2024 10

New prostate cancer diagnostic pathway paves way for general screening

bySwedish Research CouncilCredit: Pixabay/CC0 Public DomainIn screening for prostate cancer, the risk of overdiagnosis can be halved, a University of Gothenburg study shows. With the proposed di

Updated on: January 12,2024 10

New prostate cancer diagnostic pathway paves way for general screening

bySwedish Research CouncilCredit: Pixabay/CC0 Public DomainIn screening for prostate cancer, the risk of overdiagnosis can be halved, a University of Gothenburg study shows. With the proposed di

Updated on:January 12,2024 10

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

Updated on: January 12,2024 18

New bispecific antibody demonstrates clinical activity in patients with multiple myeloma

byAmerican Association for Cancer ResearchCredit: Unsplash/CC0 Public DomainPatients with relapsed or refractory multiple myeloma who were treated with the two highest doses of REGN5459, a bispe

Updated on:January 12,2024 18

Researchers identified a protein associated with breast cancer

by Cathy Frisinger,UT Southwestern Medical CenterDr. Yingfei Wang says depleting the protein ZMYND8 blocks the growth of new blood vessels in breast cancer. Credit: UT Southwestern Medical Cente

Updated on: June 19,2024 4

Researchers identified a protein associated with breast cancer

by Cathy Frisinger,UT Southwestern Medical CenterDr. Yingfei Wang says depleting the protein ZMYND8 blocks the growth of new blood vessels in breast cancer. Credit: UT Southwestern Medical Cente

Updated on:June 19,2024 4

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on: July 05,2024 0

Destroying cancer-causing RNA could lead to bespoke treatments, say scientists

byPeter MacCallum Cancer CentreThe efficiency of PspCas13b silencing is highly variable between crRNAs. Credit:Nature Structural & Molecular Biology(2024). DOI: 10.1038/s41594-02

Updated on:July 05,2024 0

A new natural killer cell therapy product with promising anticancer effects

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Schematic diagram of the MBP technology in NK cells and expected role in the tumor site. (A) Schematic illustration of cytokine engineered

Updated on: February 03,2024 19

A new natural killer cell therapy product with promising anticancer effects

by DGIST (Daegu Gyeongbuk Institute of Science and Technology)Schematic diagram of the MBP technology in NK cells and expected role in the tumor site. (A) Schematic illustration of cytokine engineered

Updated on:February 03,2024 19

Researchers identify potential genetic variants linked to increased cancer risk in children with birth defects

by Children's Hospital of PhiladelphiaDemographic information of the cohort. aPhenotype information of the discovery cohort; bPhenotype information of the validation cohort; c&nbs

Updated on: February 01,2024 15

Researchers identify potential genetic variants linked to increased cancer risk in children with birth defects

by Children's Hospital of PhiladelphiaDemographic information of the cohort. aPhenotype information of the discovery cohort; bPhenotype information of the validation cohort; c&nbs

Updated on:February 01,2024 15

Researchers discover a mechanism that controls the identity of stem cells

by University of California, IrvineCredit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.10.036Researchers at the University of California, Irvine, discovered a mechanism that contr

Updated on: February 03,2024 15

Researchers discover a mechanism that controls the identity of stem cells

by University of California, IrvineCredit:Molecular Cell(2023). DOI: 10.1016/j.molcel.2023.10.036Researchers at the University of California, Irvine, discovered a mechanism that contr

Updated on:February 03,2024 15

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on: May 09,2024 4

Encyclopedic tumor analysis for guiding treatment of advanced, broadly refractory cancers

by OncotargetCONSORT diagram. Credit: Ajay SrinivasanRESILIENT was a single arm, open label, phase II/III study to test if label agnostic therapy regimens guided by Encyclopedic Tumor Analysis can off

Updated on:May 09,2024 4

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on: October 24,2024 0

Analysis calculates $725M in economic potential from expanded cancer treatment access

by Katja Wie, WifORRatio of cost of treatment to GDP per capita. Credit:The Lancet OncologyCommissionA recent analysis,publishedinThe Lancet Oncology, calculates that inc

Updated on:October 24,2024 0

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on: January 30,2024 14

Fixed-duration ibrutinib plus venetoclax may benefit patients with high-risk chronic lymphocytic leukemia

by American Association for Cancer ResearchCredit: CC0 Public DomainFirst-line ibrutinib (Imbruvica) plus venetoclax (Venclexta) led to high response and survival rates in patients with chronic l

Updated on:January 30,2024 14

Researchers identify protein that contributes to racial disparities in prostate cancer

by Roswell Park Cancer InstituteDrs. Dhyan Chandra, left, and Rahul Kumar led the Roswell Park research team that has proposed a new strategy for treating prostate cancer in some men. Credit: Ros

Updated on: June 22,2024 6

Researchers identify protein that contributes to racial disparities in prostate cancer

by Roswell Park Cancer InstituteDrs. Dhyan Chandra, left, and Rahul Kumar led the Roswell Park research team that has proposed a new strategy for treating prostate cancer in some men. Credit: Ros

Updated on:June 22,2024 6